BioRestorative CEO Lance Alstodt, CFO Robert Kristal resign effective immediately

• BioRestorative Therapies disclosed a leadership shake-up with resignations across its board and C-suite in mid-July 2026.
• Director David Rosa resigned from the board effective July 11, 2026, stepping down from all committees, including the compensation committee.
• Lance Alstodt resigned effective July 13, 2026, exiting as president, chief executive officer, chairman, officer, and director.
• Chief Financial Officer Robert Kristal also resigned effective July 13, 2026, leaving all officer and director roles.
• Alstodt and Kristal cited “Good Reason,” tied to a claimed “Change in Control” related to board composition changes in June 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioRestorative Therapies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-033593), on July 16, 2026, and is solely responsible for the information contained therein.